Shanghai INT Medical Instruments Co

Shanghai INT Medical Instruments Co Documents

Documents

0

Ticker

1501.HK

ISIN

CNE100003NH7

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Shanghai INT Medical Instruments Co SEC Filings

Type
Report
Date
No documents available

Shanghai INT Medical Instruments Co Documents 2026

This page contains all official documents and SEC filings for Shanghai INT Medical Instruments Co stock (1501.HK, ISIN: CNE100003NH7). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Shanghai INT Medical Instruments Co's regulatory filings.

Shanghai INT Medical Instruments Co Stock analysis

Shanghai INT Medical Instruments Co Shanghai INT Medical Instruments Co Ltd, listed on the Hong Kong Stock Exchange under ticker 1501.HK, is a Shanghai-based healthcare company specializing in the research, development, manufacturing, and sales of interventional and implantable medical devices. The company went public on November 8, 2019, and currently employs 1,532 people. Its primary focus is on cardiovascular intervention devices, including related molds and accessories, though it also develops other interventional and implantable medical devices such as neurological and endocardial products. The firm's product portfolio includes items like inflation devices, introducer sets, and guidewires. Operations are conducted domestically within China and internationally in markets including Europe and the United States. The company's website is https://www.kdl-int.com/.